Reflections on the 50th annual meeting of the EASD


  • Mike Gwilt



50th Annual Meeting of the European Association for the Study of Diabetes, Vienna, Austria, 13–19 September, 2014. See

Bailey CJ et al. Metformin – the Gold Standard: A Scientific Handbook, 2007, Wiley (ISBN 978-0-470-72541-2).

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854-65.

Kooy A, de Jager J, Lehert P, et al. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med 2009;169:616-25.

Glucose Lowering in Non-Diabetic Hyperglycaemia Trial. See

Holman RR, Paul SK, Bethal MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359: 1577-89.

Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New Engl J Med 2005;353:2643-53.

Holman RR, Paul SK, Bethel MA, et al. Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1565-76.






Meeting Reports